Drawing for CALOCURB CLINICAL

USPTO serial 79284544

CALOCURB CLINICAL

Reviewed by CopyMark Law Group

Reg. 6192252Status 700Renewal
Filing date
Status date
Registration date
Nov 10, 2020
Examiner
CLARK, ROBERT C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CALOCURB CLINICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jacqueline L. Patt

Jacqueline L. Patt Markery Law LLCP.O. Box 84150Gaithersburg, MD 20883-4150UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations, namely, weight management supplements and appetite suppression supplements; sanitary preparations for medical purposes; dietetic food and substances, namely, meal replacement bars and beverages adapted for medical or veterinary use, food for babies and infants; dietary supplements for humans and animals; medicines for dental purposes; vitamins, vitamin preparations and vitamin supplements; minerals and mineral supplements; nutritional supplements; protein foods for dietetic purposes in the nature of protein supplement shakes; protein foods, products and preparations for use as additives for human consumption, namely, meal replacement bars and ready to drink meal replacement shakes; beverages containing added vitamins and vitamin supplements for use as a nutritional and weight management supplement; medicinal naturopathic preparations for weight management, medicinal herbal preparations, royal jelly nutritional supplements; homeopathic supplements and pharmaceutical substances for appetite suppression and weight management; sanitary preparations and substances, namely, sterilizers and disinfectants; dietetic preparations and substances, namely, bread, crackers, beverages, infusions, meal replacement bars, and confectionery adapted for medical use; pharmaceutical preparations for skin care; dietetic food and beverages adapted for medical use; herbal supplements for human consumption; herbal formulations for human consumption as nutritional supplements; powdered milk for babies and infants; electrolyte drinks for medical purposes; medicated confectionery; medicated gel capsules sold empty for pharmaceuticals; medicated chewing gum; casein being dietary supplements; drug delivery agents in the nature of hard shell and soft gel capsule formulations including delayed and modified release of active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the nature of oral powders and granules that facilitate delivery of pharmaceutical preparations for medical use; drug delivery agents in the nature of oral liquids that facilitate delivery of pharmaceutical preparations for medical use; chewing gums for medical use; dietary nutritional supplements not for medical purposes; protein dietary supplements; aloe vera preparations for pharmaceutical purposes; dietary supplements for appetite suppression, dietary supplements for weight management; medicines for treatment of obesity, heart disease and stroke, high blood pressure, diabetes, gallbladder disease, osteoarthritis, gout, asthma and cancer; dietetic substances adapted for medical use, namely, meal and food replacements in powder and liquid form; dietary supplements for humans and babies' foods, dietary supplements for animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 14, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 23, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 23, 2021FIMPFINAL DISPOSITION PROCESSED—
Feb 10, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 10, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 20, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 20, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2020ALIEASSIGNED TO LIE—
Jul 7, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2020RFNTREFUSAL PROCESSED BY IB—
May 14, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 14, 2020RFRRREFUSAL PROCESSED BY MPU—
May 7, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 5, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 4, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2020DOCKASSIGNED TO EXAMINER—
May 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 30, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance